Facebook
Twitter
LinkedIn
ForwardPULSE- Checking in or checking out? Use of Immune Checkpoint Inhibitors in Patients with Compromised Immune Systems - August 19, 2020
New medication or old medications with new uses, as well as new treatment guidelines are constantly coming out. Pharmacists need to be aware of clinical controversies and stay up-to-date with the pharmacotherapy and therapeutics of all medications. Pharmacists will gain knowledge of a current clinical controversy and become aware of best medication practices.
Target Audience
Pharmacists at UPMC, Pharmacy Faculty at PittPharmacy, Pharmacy Residents, Pharmacy Students
Learning Objectives
1. Explain the mechanism of immune checkpoint inhibition in the treatment of cancer.
2. Discuss concerns with use of checkpoint inhibitors in patients with impaired immunity.
3. Identify patients with compromised immune systems who may be appropriate candidates for immunotherapy.
New medication or old medications with new uses, as well as new treatment guidelines are constantly coming out. Pharmacists need to be aware of clinical controversies and stay up-to-date with the pharmacotherapy and therapeutics of all medications. Pharmacists will gain knowledge of a current clinical controversy and become aware of best medication practices.
Katharine G. Woodworth, PharmD
PGY2 Oncology Pharmacy Resident
UPMC Presbyterian-Shadyside
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.